These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4315254)

  • 21. Role of pertussigen (pertussis toxin) on the mouse protective activity of vaccines made from Bordetella species.
    Munoz JJ; Peacock MG
    Microbiol Immunol; 1989; 33(4):341-55. PubMed ID: 2549344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of adjuvants on the antibody response to a hapten on a thymus-independent carrier.
    Del Guercio P
    Nat New Biol; 1972 Aug; 238(85):213-5. PubMed ID: 4115393
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunotherapeutic Potential of Mollusk Hemocyanins in Combination with Human Vaccine Adjuvants in Murine Models of Oral Cancer.
    Mora Román JJ; Del Campo M; Villar J; Paolini F; Curzio G; Venuti A; Jara L; Ferreira J; Murgas P; Lladser A; Manubens A; Becker MI
    J Immunol Res; 2019; 2019():7076942. PubMed ID: 30847353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of reagin synthesis in the rat with associated and dissociated hemocyanin: effect of antilymphocyte serum.
    White GJ; Holm MS
    J Immunol; 1973 Feb; 110(2):327-34. PubMed ID: 4346094
    [No Abstract]   [Full Text] [Related]  

  • 25. The antigen of Bordetella pertussis that induces bactericidal antibody and its relationship to protection of mice.
    Ackers JP; Dolby JM
    J Gen Microbiol; 1972 Apr; 70(2):371-82. PubMed ID: 4338965
    [No Abstract]   [Full Text] [Related]  

  • 26. Antibody response to a protein antigen (ovalbumin) in dissociated spleen cell cultures from primed mice. Evidence for a suppressive effect of antigen.
    Salaman MR; Britton S
    Immunology; 1973 Jan; 24(1):55-65. PubMed ID: 4346599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potentiation of rat reaginic (IgE) antibody by helminth infection. Simultaneous potentiation of separate reagins.
    Jarrett EE; Stewart DC
    Immunology; 1972 Nov; 23(5):749-55. PubMed ID: 4344216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity of fungi for the production of reaginic antibody in the rat.
    Tada T; Okumura K; Takemori T; Arai T
    Allerg Immunol (Leipz); 1974-1975; 20-21(4):427-34. PubMed ID: 4377863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of various adjuvant regimens and of nematode infection on the reaginic antibody response to egg-albumin in the rat.
    Jarrett EE; Henderson D; Riley P; White RG
    Int Arch Allergy Appl Immunol; 1972; 42(6):775-81. PubMed ID: 4340356
    [No Abstract]   [Full Text] [Related]  

  • 30. Liposomes as immunological adjuvants.
    Allison AC; Gregoriadis G
    Recent Results Cancer Res; 1976; (56):58-64. PubMed ID: 188085
    [No Abstract]   [Full Text] [Related]  

  • 31. Reduced adjuvant activity of Bordetella pertussis vaccine in mice after priming with an immunogenic threshold dose.
    Finger H; Emmerling P; Offenhammer A
    Int Arch Allergy Appl Immunol; 1970; 39(1):45-55. PubMed ID: 4318029
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of pertussis adjuvant on antibody production: the need for thymus-dependent lymphocytes.
    Hay FC; Torrigiani G
    Eur J Immunol; 1973 Oct; 3(10):657-9. PubMed ID: 4358109
    [No Abstract]   [Full Text] [Related]  

  • 33. The comparative selectivity of adjuvants for humoral and cell-mediated immunity. I. Effect on the antibody response to bovine serum albumin and sheep red blood cells of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin.
    Bomford R
    Clin Exp Immunol; 1980 Feb; 39(2):426-34. PubMed ID: 6248282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic control of immune responsiveness to a glutamic acid, alanine, tyrosine copolymer in mice. I. Linkage of responsiveness to H-2 genotype.
    Martin WJ; Maurer PH; Benacerraf B
    J Immunol; 1971 Sep; 107(3):715-8. PubMed ID: 4328471
    [No Abstract]   [Full Text] [Related]  

  • 35. The potential of adjuvants to improve immune responses against TdaP vaccines: A preclinical evaluation of MF59 and monophosphoryl lipid A.
    Agnolon V; Bruno C; Leuzzi R; Galletti B; D'Oro U; Pizza M; Seubert A; O'Hagan DT; Baudner BC
    Int J Pharm; 2015 Aug; 492(1-2):169-76. PubMed ID: 26149936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of adjuvants and stress on the production of IgE antibody in rats.
    Meacock SC; Marsden CH
    Int Arch Allergy Appl Immunol; 1973; 45(1):136-7. PubMed ID: 4353765
    [No Abstract]   [Full Text] [Related]  

  • 37. Extraction and partial purification of the histamine-sensitizing factor of Bordetella pertussis.
    Lehrer SB; Tan EM; Vaughan JH
    J Immunol; 1974 Jul; 113(1):18-26. PubMed ID: 4134061
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies on the adjuvant effect of Bordetella pertussis vaccine to sheep erythrocytes in the mouse. I. In vitro enhancement of antibody formation with normal spleen cells.
    Murgo AJ; Athanassiades TJ
    J Immunol; 1975 Oct; 115(4):928-31. PubMed ID: 170337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of rat IgE by aerosol immunization.
    Van Hout CA; Johnson HG
    J Immunol; 1972 Mar; 108(3):834-6. PubMed ID: 4334882
    [No Abstract]   [Full Text] [Related]  

  • 40. The adjuvant activity of Bordetella pertussis in mice with congenital aplasia of the thymus.
    Finger H; Hof H; Elekes E
    Z Immunitatsforsch Exp Klin Immunol; 1973 Sep; 145(5):460-6. PubMed ID: 4377483
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.